A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea

Influenza affects all age groups, but the risk of hospitalization and death due to influenza is strongly age-related and is at its highest among the elderly aged 65 years and older. The objective of this study is to compare the differences in influenza-associated disease burden under three different...

Full description

Bibliographic Details
Main Authors: Min Joo Choi, Jae-Won Yun, Joon Young Song, Karam Ko, Joaquin F. Mould, Hee Jin Cheong
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/9/1387
_version_ 1797481654628909056
author Min Joo Choi
Jae-Won Yun
Joon Young Song
Karam Ko
Joaquin F. Mould
Hee Jin Cheong
author_facet Min Joo Choi
Jae-Won Yun
Joon Young Song
Karam Ko
Joaquin F. Mould
Hee Jin Cheong
author_sort Min Joo Choi
collection DOAJ
description Influenza affects all age groups, but the risk of hospitalization and death due to influenza is strongly age-related and is at its highest among the elderly aged 65 years and older. The objective of this study is to compare the differences in influenza-associated disease burden under three different influenza vaccination strategies—the standard-dose quadrivalent influenza vaccine (QIV), high-dose QIV (HD-QIV), and MF59<sup>®</sup>-adjuvanted QIV (aQIV)—for the elderly population aged 65 years and older in South Korea. A one-year decision-tree model was developed to compare influenza disease burdens. The input data for the model were obtained from published literature reviews and surveillance data from the Korea Disease Control and Prevention Agency (KDCA). The analysis indicated that aQIV is more effective than QIV, preventing 35,390 influenza cases, 1602 influenza-associated complications, 709 influenza-associated hospitalizations, and 145 influenza-associated deaths annually. Additionally, aQIV, when compared to HD-QIV, also reduced the influenza-associated burden of disease, preventing 7247 influenza cases, 328 influenza-associated complications, 145 influenza-associated hospitalizations, and 30 influenza-associated deaths annually. Switching the vaccination strategy from QIV to aQIV is predicted to reduce the influenza-associated disease burden for the elderly in South Korea. The public health gains from aQIV and HD-QIV are expected to be comparable. Future studies comparing the effectiveness of the vaccines will further inform future vaccination strategies for the elderly in South Korea.
first_indexed 2024-03-09T22:17:42Z
format Article
id doaj.art-e450d35810084c0092f98a065f2b1508
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T22:17:42Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-e450d35810084c0092f98a065f2b15082023-11-23T19:20:11ZengMDPI AGVaccines2076-393X2022-08-01109138710.3390/vaccines10091387A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South KoreaMin Joo Choi0Jae-Won Yun1Joon Young Song2Karam Ko3Joaquin F. Mould4Hee Jin Cheong5Department of Internal Medicine, International St. Mary’s Hospital, Catholic Kwandong University College of Medicine, Incheon 22711, KoreaAsia Pacific Influenza Institute, Korea University College of Medicine, Seoul 08308, KoreaAsia Pacific Influenza Institute, Korea University College of Medicine, Seoul 08308, KoreaSeqirus Korea Ltd., Seoul 03157, KoreaSeqirus USA Inc., Summit, NJ 07901, USAAsia Pacific Influenza Institute, Korea University College of Medicine, Seoul 08308, KoreaInfluenza affects all age groups, but the risk of hospitalization and death due to influenza is strongly age-related and is at its highest among the elderly aged 65 years and older. The objective of this study is to compare the differences in influenza-associated disease burden under three different influenza vaccination strategies—the standard-dose quadrivalent influenza vaccine (QIV), high-dose QIV (HD-QIV), and MF59<sup>®</sup>-adjuvanted QIV (aQIV)—for the elderly population aged 65 years and older in South Korea. A one-year decision-tree model was developed to compare influenza disease burdens. The input data for the model were obtained from published literature reviews and surveillance data from the Korea Disease Control and Prevention Agency (KDCA). The analysis indicated that aQIV is more effective than QIV, preventing 35,390 influenza cases, 1602 influenza-associated complications, 709 influenza-associated hospitalizations, and 145 influenza-associated deaths annually. Additionally, aQIV, when compared to HD-QIV, also reduced the influenza-associated burden of disease, preventing 7247 influenza cases, 328 influenza-associated complications, 145 influenza-associated hospitalizations, and 30 influenza-associated deaths annually. Switching the vaccination strategy from QIV to aQIV is predicted to reduce the influenza-associated disease burden for the elderly in South Korea. The public health gains from aQIV and HD-QIV are expected to be comparable. Future studies comparing the effectiveness of the vaccines will further inform future vaccination strategies for the elderly in South Korea.https://www.mdpi.com/2076-393X/10/9/1387influenzadisease burdenaverted outcomesquadrivalent vaccineelderly
spellingShingle Min Joo Choi
Jae-Won Yun
Joon Young Song
Karam Ko
Joaquin F. Mould
Hee Jin Cheong
A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea
Vaccines
influenza
disease burden
averted outcomes
quadrivalent vaccine
elderly
title A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea
title_full A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea
title_fullStr A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea
title_full_unstemmed A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea
title_short A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea
title_sort comparative analysis of influenza associated disease burden with different influenza vaccination strategies for the elderly population in south korea
topic influenza
disease burden
averted outcomes
quadrivalent vaccine
elderly
url https://www.mdpi.com/2076-393X/10/9/1387
work_keys_str_mv AT minjoochoi acomparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea
AT jaewonyun acomparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea
AT joonyoungsong acomparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea
AT karamko acomparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea
AT joaquinfmould acomparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea
AT heejincheong acomparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea
AT minjoochoi comparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea
AT jaewonyun comparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea
AT joonyoungsong comparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea
AT karamko comparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea
AT joaquinfmould comparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea
AT heejincheong comparativeanalysisofinfluenzaassociateddiseaseburdenwithdifferentinfluenzavaccinationstrategiesfortheelderlypopulationinsouthkorea